MAM
Honda drives forward as Takashi Nakajima takes the wheel at HCIL
MUMBAI: Honda Cars India Ltd (HCIL) is shifting gears at the top, with Takashi Nakajima set to take over as president & CEO from 1 April 2025. Nakajima, a Honda veteran with over 30 years of global experience, succeeds Takuya Tsumura, who will return to Japan after an impactful three-year stint at the helm of HCIL.
During his tenure in India, Tsumura bolstered Honda’s premium brand positioning, enhanced customer-centric solutions, and steered the company toward profitable growth. His leadership saw the launch of several landmark models, including the Honda City e:HEV, India’s first mainstream hybrid model; the Honda Elevate, the brand’s new global SUV; and the 3rd Generation Amaze, a refreshed take on Honda’s popular compact sedan.
Under his watch, Honda’s export operations expanded, with the Made-in-India elevate hitting Japanese roads. Tsumura also focused on integrated marketing campaigns to engage a diverse audience, while implementing efficiency-driven initiatives to enhance both customer experience and dealer profitability.
Bringing decades of expertise from markets including Japan, China, Spain, Czech Republic, and Russia, Nakajima is no stranger to strategic growth. His impressive career spans business planning, product strategy, marketing, and sales promotion, with a recent role as president of Honda Motor Russia. He also led product planning and corporate communications for Honda’s domestic automobile business in Japan.
With Honda gearing up for its first Battery Electric Vehicle (BEV) launch in India, Nakajima’s entry signals a bold new chapter in Honda’s journey. As he prepares to take the wheel, all eyes are on how he will steer innovation, expansion, and electrification in one of the world’s most dynamic auto markets.
As the industry shifts towards sustainable mobility, Nakajima’s leadership promises to accelerate Honda’s evolution in India. With a strong foundation laid by Tsumura, the road ahead looks primed for bigger ambitions, smarter technology, and an electrifying future.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
